<DOC>
	<DOC>NCT00526552</DOC>
	<brief_summary>To evaluate the efficacy of rosuvastatin in Korean dyslipidemia patients with diabetes</brief_summary>
	<brief_title>Crestor RAPID (The Efficacy of RosuvAstatin for Korean Dyslipidemia PatIents With Diabetes)</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Dyslipidemias</mesh_term>
	<mesh_term>Rosuvastatin Calcium</mesh_term>
	<criteria>Hyperlipidemia patients who are prescribed with rosuvastatin 10mg, based on clinical grounds and fulfil the following criteria 1. Over 18 years of age 2. Diagnosed with DM based on fasting or postload glucose data and/or clinical assessment by the clinician 1. Patients already taking other hyperlipidemic agents 2. Patients who do not fulfil the indication criteria for statin therapy 3. Patients who do not have baseline and/or followup lipid data to verify the efficacy data</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2010</verification_date>
	<keyword>dyslipidemia</keyword>
	<keyword>rosuvastatin</keyword>
	<keyword>diabetes</keyword>
	<keyword>cholesterol</keyword>
	<keyword>Naturalistic</keyword>
	<keyword>Observational</keyword>
</DOC>